Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals
News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass.–(BUSINESS WIRE)– Waters Corporation (NYSE:WAT) today introduced the... Read more